Key Metrics
Factor Lens
Seasonal Performance
Dividends
Per-share amounts adjusted for stock splits.
Last 12 Payouts
| Period | Ex-Date | Amount / Share |
|---|---|---|
| Q1 2026 | ~2026-06-30 | $0.6300 |
| Q4 2025 | ~2026-04-01 | $0.6300 |
| Q3 2025 | ~2025-12-31 | $0.6300 |
| Q2 2025 | ~2025-09-30 | $0.6300 |
| Q1 2025 | ~2025-06-30 | $0.5700 |
| Q4 2024 | ~2025-04-01 | $0.5700 |
| Q3 2024 | ~2024-12-31 | $0.5700 |
| Q2 2024 | ~2024-09-30 | $0.5700 |
| Q1 2024 | ~2024-06-30 | $0.5200 |
| Q4 2023 | ~2024-03-31 | $0.5200 |
| Q3 2023 | ~2023-12-31 | $0.5200 |
| Q2 2023 | ~2023-09-30 | $0.5200 |
Financial Trends
Revenue & Net Income
Earnings Per Share
Margins
Cash Flow
Company Overview
STERIS is a leading global provider of products and services that support patient care with an emphasis on infection prevention. The Company offers customers a unique mix of… innovative products and services, including consumable products such as detergents, endoscopy accessories, barrier products, instruments and tools; services including equipment installation and maintenance, microbial reduction of medical devices, instrument and scope repair, laboratory testing, and outsourced reprocessing; capital equipment such as sterilizers, surgical tables, and automated endoscope reprocessors; and connectivity solutions such as operating room integration. The Company operates through three reportable business segments: Healthcare (providing comprehensive offerings for healthcare providers worldwide with a focus on sterile processing departments and procedural centers), Applied Sterilization Technologies (supporting medical device and pharmaceutical manufacturers through contract sterilization and laboratory testing facilities and integrated sterilization equipment), and Life Sciences (providing a comprehensive offering of products and services designed to support biopharmaceutical and medical device manufacturing facilities). The bulk of STERIS's revenues are derived from healthcare, medical device and pharmaceutical customers, with growth driven by aging populations, increased demand for medical procedures, and customer desires to operate more efficiently.
- Name
- STERIS plc
- Industry
- Medical Instruments & Supplies
- CEO
- Daniel A. Carestio · President and Chief Executive Officer
- Employees
- 14,250 as of 2025-03-31
- IPO Date
- 2019-01-31
- Phone
- (353) 1 232 2000
- Address
- 70 Sir John Rogerson's Quay, Dublin, Dublin 2 D02 R296
- Website
- http://www.steris.com
Key Executives
| Name | Title | FY Pay |
|---|---|---|
| Daniel A. Carestio | President and Chief Executive Officer | — |
Latest News
- 2026-04-21
- 2026-04-10
- 2026-04-10
- 2026-04-10
- 2026-04-08
-
2026-04-06
Aberdeen Group plc Buys 20,097 Shares of STERIS plc $STE defenseworld.net
-
2026-03-30
Assenagon Asset Management S.A. Cuts Holdings in STERIS plc $STE defenseworld.net
- 2026-03-26